 | • レポートコード：GIR-22F19158 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Approved COVID-19 Vaccines Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の承認済みCOVID-19ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 承認済みCOVID-19ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・コンポーネントウイルスワクチン、ホールウイルスワクチン アプリケーション別セグメントは次のように区分されます。 ・大人、子供、高齢者 世界の承認済みCOVID-19ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、承認済みCOVID-19ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な承認済みCOVID-19ワクチンメーカーの企業概要、2019年～2022年までの承認済みCOVID-19ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な承認済みCOVID-19ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別承認済みCOVID-19ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの承認済みCOVID-19ワクチンのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での承認済みCOVID-19ワクチン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および承認済みCOVID-19ワクチンの産業チェーンを掲載しています。 ・第13、14、15章では、承認済みCOVID-19ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 承認済みCOVID-19ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：コンポーネントウイルスワクチン、ホールウイルスワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：大人、子供、高齢者 - 世界の承認済みCOVID-19ワクチン市場規模・予測 - 世界の承認済みCOVID-19ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：コンポーネントウイルスワクチン、ホールウイルスワクチン ・アプリケーション別分析2017年-2028年：大人、子供、高齢者 ・承認済みCOVID-19ワクチンの北米市場分析 - 承認済みCOVID-19ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 承認済みCOVID-19ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・承認済みCOVID-19ワクチンのヨーロッパ市場分析 - ：承認済みCOVID-19ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：承認済みCOVID-19ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・承認済みCOVID-19ワクチンのアジア太平洋市場分析 - 承認済みCOVID-19ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 承認済みCOVID-19ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・承認済みCOVID-19ワクチンの南米市場分析 - 承認済みCOVID-19ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 承認済みCOVID-19ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・承認済みCOVID-19ワクチンの中東・アフリカ市場分析 - 承認済みCOVID-19ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 承認済みCOVID-19ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Approved COVID-19 Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Approved COVID-19 Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Adults accounting for % of the Approved COVID-19 Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Component Viral Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, and GlaxoSmithKine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Approved COVID-19 Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Component Viral Vaccines
Whole Virus Vaccines
Market segment by Application can be divided into
Adults
Children
Elderly
The key market players for global Approved COVID-19 Vaccines market are listed below:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Approved COVID-19 Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Approved COVID-19 Vaccines, with price, sales, revenue and global market share of Approved COVID-19 Vaccines from 2019 to 2022.
Chapter 3, the Approved COVID-19 Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Approved COVID-19 Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Approved COVID-19 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Approved COVID-19 Vaccines.
Chapter 13, 14, and 15, to describe Approved COVID-19 Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Approved COVID-19 Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Approved COVID-19 Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Component Viral Vaccines
1.2.3 Whole Virus Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Approved COVID-19 Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Global Approved COVID-19 Vaccines Market Size & Forecast
1.4.1 Global Approved COVID-19 Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Approved COVID-19 Vaccines Sales in Volume (2017-2028)
1.4.3 Global Approved COVID-19 Vaccines Price (2017-2028)
1.5 Global Approved COVID-19 Vaccines Production Capacity Analysis
1.5.1 Global Approved COVID-19 Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Approved COVID-19 Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Approved COVID-19 Vaccines Market Drivers
1.6.2 Approved COVID-19 Vaccines Market Restraints
1.6.3 Approved COVID-19 Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna Approved COVID-19 Vaccines Product and Services
2.1.4 Moderna Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CanSino Biologicals
2.2.1 CanSino Biologicals Details
2.2.2 CanSino Biologicals Major Business
2.2.3 CanSino Biologicals Approved COVID-19 Vaccines Product and Services
2.2.4 CanSino Biologicals Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Inovio Pharmaceuticals
2.3.1 Inovio Pharmaceuticals Details
2.3.2 Inovio Pharmaceuticals Major Business
2.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Product and Services
2.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shenzhen Geno-Immune Medical Institute
2.4.1 Shenzhen Geno-Immune Medical Institute Details
2.4.2 Shenzhen Geno-Immune Medical Institute Major Business
2.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product and Services
2.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKine
2.5.1 GlaxoSmithKine Details
2.5.2 GlaxoSmithKine Major Business
2.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Product and Services
2.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Approved COVID-19 Vaccines Product and Services
2.6.4 Pfizer Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Johnson＆Johnson
2.7.1 Johnson＆Johnson Details
2.7.2 Johnson＆Johnson Major Business
2.7.3 Johnson＆Johnson Approved COVID-19 Vaccines Product and Services
2.7.4 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Heat Biologics
2.8.1 Heat Biologics Details
2.8.2 Heat Biologics Major Business
2.8.3 Heat Biologics Approved COVID-19 Vaccines Product and Services
2.8.4 Heat Biologics Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Approved COVID-19 Vaccines Product and Services
2.9.4 Sanofi Approved COVID-19 Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Approved COVID-19 Vaccines Breakdown Data by Manufacturer
3.1 Global Approved COVID-19 Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Approved COVID-19 Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Approved COVID-19 Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Approved COVID-19 Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Approved COVID-19 Vaccines Manufacturer Market Share in 2021
3.5 Global Approved COVID-19 Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Approved COVID-19 Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Approved COVID-19 Vaccines Market Size by Region
4.1.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Approved COVID-19 Vaccines Revenue by Region (2017-2028)
4.2 North America Approved COVID-19 Vaccines Revenue (2017-2028)
4.3 Europe Approved COVID-19 Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Approved COVID-19 Vaccines Revenue (2017-2028)
4.5 South America Approved COVID-19 Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Approved COVID-19 Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Approved COVID-19 Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Approved COVID-19 Vaccines Revenue by Type (2017-2028)
5.3 Global Approved COVID-19 Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Approved COVID-19 Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Approved COVID-19 Vaccines Revenue by Application (2017-2028)
6.3 Global Approved COVID-19 Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Approved COVID-19 Vaccines Sales by Type (2017-2028)
7.2 North America Approved COVID-19 Vaccines Sales by Application (2017-2028)
7.3 North America Approved COVID-19 Vaccines Market Size by Country
7.3.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Approved COVID-19 Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Approved COVID-19 Vaccines Sales by Type (2017-2028)
8.2 Europe Approved COVID-19 Vaccines Sales by Application (2017-2028)
8.3 Europe Approved COVID-19 Vaccines Market Size by Country
8.3.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Approved COVID-19 Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Approved COVID-19 Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Approved COVID-19 Vaccines Market Size by Region
9.3.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Approved COVID-19 Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Approved COVID-19 Vaccines Sales by Type (2017-2028)
10.2 South America Approved COVID-19 Vaccines Sales by Application (2017-2028)
10.3 South America Approved COVID-19 Vaccines Market Size by Country
10.3.1 South America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Approved COVID-19 Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Approved COVID-19 Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Approved COVID-19 Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Approved COVID-19 Vaccines Market Size by Country
11.3.1 Middle East & Africa Approved COVID-19 Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Approved COVID-19 Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Approved COVID-19 Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Approved COVID-19 Vaccines
12.3 Approved COVID-19 Vaccines Production Process
12.4 Approved COVID-19 Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Approved COVID-19 Vaccines Typical Distributors
13.3 Approved COVID-19 Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer